Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Martin Dreyling
Mantle Cell Lymphoma
Takeshi Sugio
T-cell lymphoma
Sahand Hormoz
MPN
Venkata Lokesh Battula
immunotherapy and AML
Sriram Sundaravel
AML stem cells
Liling Wan
AML
Reina Takeda
AML
Christopher Flowers
clinical trial access
Grzegorz Nowakowski
Clinical trial access
Caner Saygin
T-ALL
Jaehyuk Choi
T-cell lymphoma
Yan Liu
MDS
Frederike Kramer
MPNs
Coleman Lindsley
AML/MDS
Nicoletta Cieri
AML and transplantation
Suzanne Lentzsch
Myeloma
Jaroslaw Maciejewski
bone marrow failure
Marco Ruella
Immunotherapy for T-cell lymphoma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Anthony Letai
improving CAR-T
Michael Savona
MDS and leukemia
Oreofe Odejide
Equity in Access
Catriona Jamieson
cancer stem cell biology
Stephen Oh
myeloproliferative neoplasms
Robert Soiffer
transplantation
Qing Yi
Novel CAR-T
Paul Beavis
immunotherapy in myeloma
Julia Maxson
AML
Kasey Leger
pediatric blood cancers
Bingyi Chen
AML immunotherapy
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Paolo Caimi
CAR-T clinical trial for CLL
Amin Sobh
Myeloma biology
Kura Oncology
MLL leukemia, AML
Ronald Levy
immunotherapies, COVID-19
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
F. Lennie Wong
Equity in Access
Mark Murakami
follicular lymphoma
Gaurav Goyal
Erdheim-Chester Disease
Marc Seifert
Hairy cell leukemia
Kerry Rogers
CLL
Carl Allen
pediatric blood cancers
Jessica Stewart
Epstein-barr virus and lymphomas
Adam de Smith
pediatric ALL and Down Syndrome
Faron Pharmaceuticals
immunotherapy, MDS
Daniel Lucas
bone marrow and leukemia biology
Tanya Siddiqi
clinical trial access
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Areej El-Jawahri
transplant survivorship
Nicola Vannini
Aging and CAR-T success
Thomas Koehnke
leukemia
Alfred Garfall
myeloma immunotherapy
Christian Steidl
B-cell lymphomas
Justine Kahn
pediatric leukemia and lymphoma
Frederick Locke
lymphoma and immunotherapy
Daniel Herranz
T-ALL
Courtney Jones
AML metabolism
Luca Busino
DLBCL
Keisuke Ito
blood cancer stem cells and MDS metabolism
Gianpietro Dotti
CAR T and AML
Caron Jacobson
lymphoma and immunotherapy
Hao Jiang
DNA biology and leukemia
Liran Shlush
pre-leukemia
John Crispino
MPNs, myelofibrosis
Robert Orlowski
(Smoldering) Multiple Myeloma
Ana Vujovic
AML
Rajni Kumari
AML
Jun Qi
Myeloma
Siegfried Janz
Myeloma immunotherapy
Abintus Bio
immunotherapy, in vivo CAR
Cailin Collins
Leukemia and pre-leukemia
Jean Koff
Disparities in DLBCL
Koichi Takahashi
AML/MDS
Jing Fu
myeloma
Jenny Wang
AML
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Ryan Wilcox
T-cell lymphoma
Megan McNerney
AML/MDS
Leandro Cerchietti
DLBCL
Helen Parsons
Equity in Access
Fenghuang Zhan
Myeloma and bone disease
Ruben Carrasco
Myeloma
Jennifer Lewis
URM Student
Wendy Stock
T-cell ALL
Nataly Cruz-Rodriguez
T-ALL and metabolism
Peter Klein
MDS
Michael Green
lymphoma biology
Rgenta Therapeutics
RNA-targeting, blood cancer
William Matsui
Myeloma
Catherine Diefenbach
DLBCL immunology
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
BioInvent International
immunotherapy, indolent NHL, CTCL
Nitin Jain
CLL
Michael Kharas
leukemia
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Nirav Shah
CAR-T for lymphoma
Manyi Wei
acute megakaryoblastic leukemia
Suman Paul
T cell cancers and immunotherapy
Stephen Gottschalk
pediatric leukemia and CAR-T
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Qingyu Luo
BPDCN
Thorsten Zenz
Hairy cell leukemia
Matthew Frank
Lymphoma CART therapy
Lawrence Boise
CART and myeloma
Markus Muschen
leukemia and lymphoma biology
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Tomasz Skorski
myeloproliferative neoplasms, AML
Eugenio Morelli
Myeloma
Wendy Béguelin
follicular lymphoma
Trent Hall
MDS
Lev Kats
myeloma and epigenetics
Enrico Tiacci
Hairy cell leukemia
Shazia Nakhoda
Equity in Access
Stephen Nimer
myeloid cancer biology
Stacie Dusetzina
Equity in Access
Craig Jordan
AML
Maximilian Stahl
AML immunotherapy
Jolanta Grembecka
leukemia therapeutics
Saar Gill
AML immunotherapy
Alexey Danilov
lymphoma
Andrew Lane
BPDCN
Enterome
vaccine, FL, MZL
Susan Schwab
cancer immunology
Kimberly Stegmaier
childhood blood cancers
Christopher Booth
BPDCN
Ricky Johnstone
lymphoma and myeloma
Tycel Phillips
Mantle Cell Lymphoma
Jalpa Doshi
Equity in Access
Christian Marinaccio
MLL leukemias
Mark Dawson
B-ALL and CAR-T resistance
James Rubenstein
Lymphoma of the Central Nervous System
Anushree Vichare
Equity in Access
Jeffrey Magee
pediatric AML
Daisuke Nakada
preleukemia, leukemia
Sigurður Kristinsson
Smoldering myeloma
Siddhartha Jaiswal
preleukemia
Jennifer Woyach
CLL trials
Christopher Porter
Leukemia, lymphoma
John DiPersio
trispecific antibody for AML and MDS
Adam Olszewski
Follicular and marginal zone lymphoma
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Neha Mehta-Shah
T-cell lymphoma
Eric Pietras
AML
Noemí Puig Morón
Myeloma
Lindsey Montefiori
pediatric leukemia
Yubin Zhou
peripheral T cell lymphoma
Piers Patten
COVID-19
Sham Mailankody
Myeloma immunotherapy clinical trials
Carl June
CAR T immunotherapy
Nizar Bahlis
Myeloma immunotherapy
Jayna Mistry
aging and leukemias
Thomas Kipps
Hairy Cell Leukemia
Tyler Parsons
MPN and AML
Caroline Arber
myeloma CAR-T
Peter Croucher
Multiple Myeloma
Jeetayu Biswas
splicing in myeloid diseases
Daniel Pollyea
AML
Roland Walter
Antibody-based AML therapies
Huda Salman
CMML
Steven Treon
Lymphomas and Waldenstrom's
Meng Li
Equity in Access
Mendel Goldfinger
MDS/AML trials for the elderly
Riccardo Dalla-Favera
lymphoma (DLBCL)
Pooja Khandelwal
bone marrow transplantation
Mark Hamilton
DLBCL and CAR-T
Taishi Yonezawa
AML
Rong Lu
preleukemia, leukemia
Jennifer Trowbridge
aging and leukemia
Bailee Kain
AML and African ancestry
Fahmin Basher
transplant and GvHD
Eirini Papapetrou
blood cancer stem cells
Philippe Armand
follicular lymphoma
Steven Horwitz
T-cell lymphomas
Joachim Yahalom
Lymphoma
Jianguo Tao
Mantle Cell Lymphoma
Alison Moskowitz
lymphoma therapeutics
Mala Shanmugam
myeloma
Ravi Bhatia
transplantation
Teresa Palomero
Peripheral T-cell Lymphoma
Anouchka Laurent
T-cell lymphoma
Hong Wen
AML
Armin Rashidi
gut bacteria and transplant success
Tak Mak
Immunotherapy
Eric Padron
CMML
Kirk Schultz
pediatric transplantation
Inhye Ahn
CLL
Gareth Morgan
smoldering myeloma, MGUS
Marina Konopleva
MDS/AML metabolism
Nicolas Nassar
pediatric leukemia
Sisi Chen
leukemia
Catherine Bollard
pediatric blood cancers and immunotherapy
George Vassiliou
Leukemia Prevention
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Sam Butterworth
CMML
Ann-Kathrin Eisfeld
Racial diversity in AML
Margaret Shipp
lymphoma biology
Sarah Tasian
pediatric leukemias
Richard Lock
T-ALL
Jonathon Cohen
lymphoma clinical trial access in Georgia
Logan Spector
childhood leukemia epidimiology
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Steven Park
follicular lymphoma
Lucy Godley
preleukemia
Brian Dalton
DNA mutations and myeloid cancers
Randall Davis
CLL
Bing Carter
p53 mutant AML
Christine Zhang
AML
Britta Will
Leukemia and pre-leukemia
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Sheng Li
Aging and AML
Madhav Dhodapkar
multiple myeloma immunotherapy
H. Irene Su
Equity in Access
Raymond Mailhot
Equity in Access
Lakshmi Nayak
brain tumors in lymphoma
Ari Melnick
epigenetics and lymphoma
Kathleen Sakamoto
pediatric AML
Elliot Stieglitz
CMML
Alieen Rowan
Adult T cell leukemia/lymphoma
Simona Colla
Myeloma biology
Pietro Genovese
transplant and AML
Courtney DiNardo
clinical trials, AML
Lori Muffly
Equity in Access
Jonas Jutzi
myeloproliferative neoplasms
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Thomas LeBlanc
palliative care
Shannon Maude
Immunotherapy for ALL
Jing Yang
Myeloma
Srividya Swaminathan
pediatric, immunotherapy
Daniel Starczynowski
MDS and AML
Soheil Meshinchi
pediatric AML
Roberta Zappasodi
lymphoma, immunotherapy
ImCheck Therapeutics
immunotherapy, AML
Dimericon Therapeutics
dimericons, blood cancer
Jonathan Licht
DNA biology, myeloma
Timothy Graubert
AML and MDS biology
Alex Kentsis
pediatric leukemias
Sergei Doulatov
Leukemias
Xu Ji
Equity in Access
Michael Wang
Mantle Cell Lymphoma
Dane Vassiliadis
blood cancer biology
Arash Alizadeh
blood cancer biology and diagnosis
Jianhua Yu
myeloma immunotherapy
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Michaela Reagan
Multiple Myeloma
Dan Landau
cancer evolution biology
Yiman Liu
Epigenetics and leukemia
Amit Verma
AML/MDS
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Daniel Thomas
Myelofibrosis
Affimed
immunotherapy, HL, PTCL
Paolo Strati
Non-Hodgkin Lymphoma
Jake Shortt
precision therapy for aggressive lymphomas
Catherine Smith
leukemia
Yoke Seng Lee
AML
Yibin Yang
Lymphoma
Bruno Paiva
smoldering myeloma
Brian Walker
smoldering myeloma, MGUS
Carma Bylund
Equity in Access
Grant Challen
preleukemia, leukemia
Omar Abdel-Wahab
Hairy cell leukemia
John Leonard
lymphoma research
Adi Nagler
Bronchiolitis obliterans after transplant
Ravindra Majeti
preleukemia, AML
Rizwan Romee
Immunotherapy
Matteo Bellone
Smoldering multiple myeloma
Michael Keller
COVID-19, immunotherapy
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Jeremy Baeten
AML
Julia Paczkowska
immunobiology of Hodgkin's disease
Alec Zhang
myeloma, immunotherapy
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL